Prestige Consumer Healthcare Inc. (PBH)
Largest Insider Buys in Sector
PBH Stock Price History Chart
PBH Stock Performance
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear …
Insider Activity of Prestige Consumer Healthcare Inc.
Over the last 12 months, insiders at Prestige Consumer Healthcare Inc. have bought $0 and sold $18M worth of Prestige Consumer Healthcare Inc. stock.
On average, over the past 5 years, insiders at Prestige Consumer Healthcare Inc. have bought $0 and sold $6.81M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,500 shares for transaction amount of $50,850 was made by P'Pool William (SVP, Gen Counsel & Corp Sec.) on 2018‑02‑12.
List of Insider Buy and Sell Transactions, Prestige Consumer Healthcare Inc.
| 2024-11-19 | Sale | Chief Executive Officer | 10,875 0.0221% | $82.60 | $898,241 | 0.00% | ||
| 2024-11-18 | Sale | Chief Executive Officer | 82,237 0.1686% | $82.56 | $6.79M | -0.27% | ||
| 2024-11-12 | Sale | Chief Financial Officer | 24,686 0.0502% | $82.01 | $2.02M | +2.39% | ||
| 2024-11-12 | Sale | See Remarks | 8,987 0.0183% | $81.85 | $735,586 | +2.39% | ||
| 2024-11-12 | Sale | SVP Quality & Regulatory | 9,885 0.0201% | $81.97 | $810,266 | +2.39% | ||
| 2024-11-12 | Sale | EVP, Marketing & Sales | 9,063 0.0184% | $82.00 | $743,166 | +2.39% | ||
| 2024-03-01 | Sale | SVP Quality & Regulatory | 172 0.0003% | $70.42 | $12,112 | +1.67% | ||
| 2024-02-28 | Sale | SVP Quality & Regulatory | 662 0.0013% | $70.30 | $46,537 | +2.44% | ||
| 2024-02-27 | Sale | SVP Quality & Regulatory | 1 <0.0001% | $70.00 | $70 | +1.99% | ||
| 2024-02-26 | Sale | SVP Quality & Regulatory | 9,677 0.0196% | $70.43 | $681,597 | +1.81% | ||
| 2024-02-23 | Sale | SVP Quality & Regulatory | 11 <0.0001% | $70.00 | $770 | +2.18% | ||
| 2024-02-15 | Sale | EVP, Marketing & Sales | 15,549 0.0319% | $69.11 | $1.07M | +3.44% | ||
| 2024-02-14 | Sale | See remarks | 26,019 0.0523% | $67.90 | $1.77M | +5.04% | ||
| 2024-02-14 | Sale | Chief Financial Officer | 30,019 0.0608% | $68.35 | $2.05M | +5.04% | ||
| 2024-02-08 | Sale | SVP Quality & Regulatory | 5,336 0.0118% | $69.00 | $368,184 | +2.95% | ||
| 2023-09-14 | Sale | SVP Quality & Regulatory | 2,540 0.0051% | $58.92 | $149,657 | +10.27% | ||
| 2023-08-08 | Sale | Chief Executive Officer | 32,800 0.0673% | $65.57 | $2.15M | -2.47% | ||
| 2023-05-24 | Sale | Chief Financial Officer | 44,011 0.0894% | $60.07 | $2.64M | +1.70% | ||
| 2023-05-19 | Sale | EVP, Marketing & Sales | 17,194 0.0346% | $60.27 | $1.04M | +0.30% | ||
| 2023-05-15 | Sale | SVP Quality & Regulatory | 8,154 0.0164% | $58.80 | $479,455 | +2.59% |
Insider Historical Profitability
| Lombardi Ronald M. | Chief Executive Officer | 320952 0.6496% | $78.75 | 2 | 14 | +27.81% |
| P'Pool William | See Remarks | 20058 0.0406% | $78.75 | 1 | 4 | +6.17% |
| Mann Peter | director | 440390 0.8914% | $78.75 | 2 | 3 | <0.0001% |
| Anderson Peter | Chief Financial Officer | 359761 0.7282% | $78.75 | 1 | 1 | <0.0001% |
| Butler Gerard | Chief Sales Officer | 289172 0.5853% | $78.75 | 2 | 1 | +12.53% |
Institutional Investor Ownership
| BlackRock | $633.54M | 17.58 | 8.73M | -3.72% | -$24.48M | 0.01 | |
| The Vanguard Group | $416.64M | 11.56 | 5.74M | -0.24% | -$1.03M | 0.01 | |
| Dimensional Fund Advisors | $229M | 6.35 | 3.16M | -8.11% | -$20.2M | 0.06 | |
| Macquarie Group | $211.87M | 5.88 | 2.92M | -4.66% | -$10.35M | 0.19 | |
| Ariel Investments | $185.83M | 5.16 | 2.56M | +0.2% | +$378,327.84 | 1.83 |